Norifumi Shioda Selected Research

Norifumi Shioda Research Topics

Disease

10	Brain Ischemia (Cerebral Ischemia) 10/2015 - 07/2006
10	Ischemia 10/2015 - 01/2006
9	Hypertrophy 01/2014 - 12/2007
5	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2021 - 06/2011
5	ATR-X syndrome 10/2020 - 06/2011
5	Cognitive Dysfunction 10/2020 - 04/2011
5	Alzheimer Disease (Alzheimer's Disease) 02/2019 - 02/2007
5	Cardiomegaly (Heart Hypertrophy) 01/2014 - 01/2009
4	Memory Disorders (Memory Loss) 10/2015 - 07/2008
3	Intellectual Disability (Idiocy) 01/2022 - 01/2011
3	X-Linked Mental Retardation (Mental Retardation, X Linked) 01/2016 - 01/2011
3	Thalassemia 01/2016 - 01/2011
3	Myocardial Infarction 11/2010 - 01/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 10/2008 - 10/2007
2	Neoplasms (Cancer) 12/2022 - 01/2019
2	Infections 04/2022 - 03/2020
2	COVID-19 04/2022 - 01/2022
2	Synucleinopathies 08/2020 - 03/2020
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2014 - 01/2014
2	Body Weight (Weight, Body) 12/2011 - 12/2007
2	Catalepsy 04/2011 - 02/2010
2	Schizophrenia (Dementia Praecox) 04/2011 - 10/2009
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2011 - 07/2006
2	Mental Disorders (Mental Disorder) 01/2010 - 10/2009
2	Bipolar Disorder (Manic Depressive Psychosis) 10/2009 - 09/2006
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2009 - 12/2007
2	Embolism (Embolus) 01/2008 - 09/2006
2	Infarction (Infarctions) 01/2008 - 01/2006
1	Fragile X Tremor Ataxia Syndrome 01/2021
1	Spastic Paraplegia Type 4 01/2021
1	Ataxia (Dyssynergia) 01/2021
1	Tremor (Tremors) 01/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 08/2020
1	Seizures (Absence Seizure) 08/2020
1	Dementia (Dementias) 03/2020
1	Parkinson Disease (Parkinson's Disease) 03/2020
1	alpha-Thalassemia 01/2018
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2013

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2006
9	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2019 - 09/2006
6	CalcineurinIBA 01/2011 - 07/2006
4	LigandsIBA 08/2020 - 10/2015
4	Adenosine Triphosphate (ATP)IBA 10/2015 - 06/2011
4	Fas Ligand Protein (Fas Ligand)IBA 01/2011 - 09/2007
4	Calcium-Calmodulin-Dependent Protein KinasesIBA 05/2010 - 09/2006
3	AcidsIBA 04/2022 - 09/2020
3	Fatty Acid Binding Protein 3IBA 08/2020 - 02/2010
3	Sigma-1 ReceptorIBA 09/2018 - 10/2010
3	Fluvoxamine (Luvox)FDA LinkGeneric 01/2014 - 10/2010
3	N-Methylaspartate (NMDA)IBA 01/2011 - 02/2007
3	CalpainIBA 01/2011 - 07/2006
3	Vanadium CompoundsIBA 01/2009 - 03/2008
3	3- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrateIBA 01/2009 - 01/2006
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2009 - 03/2008
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2008 - 09/2006
2	Antiviral Agents (Antivirals)IBA 04/2022 - 01/2022
2	Dehydroepiandrosterone (DHEA)IBA 10/2015 - 12/2011
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2014 - 11/2010
2	Angiotensin IIIBA 01/2014 - 12/2007
2	Nootropic Agents (Nootropics)IBA 04/2012 - 07/2008
2	Haloperidol (Haldol)FDA LinkGeneric 04/2011 - 02/2010
2	Antipsychotic Agents (Antipsychotics)IBA 04/2011 - 10/2009
2	spiro(imidazo- (1,2- a)pyridine- 3,2- indan)- 2(3H)- oneIBA 04/2011 - 07/2008
2	Dopamine (Intropin)FDA LinkGeneric 01/2010 - 10/2009
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2009 - 02/2007
2	3- (2- (4- (3- chloro- 2- methylphenyl)- 1- piperazinyl)ethyl)- 5,6- dimethoxyindazoleIBA 01/2009 - 12/2007
2	Endothelin-1 (Endothelin 1)IBA 01/2009 - 12/2007
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2009 - 03/2008
2	oxovanadium IVIBA 01/2009 - 10/2008
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2009 - 09/2007
2	Tyrosine (L-Tyrosine)FDA Link 01/2008 - 01/2006
2	DystrophinIBA 12/2007 - 12/2007
1	Messenger RNA (mRNA)IBA 12/2022
1	5' Untranslated Regions (5' UTR)IBA 12/2022
1	ferrous citrate FDA Link 04/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2021
1	protoporphyrin IXIBA 01/2021
1	SpastinIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	PorphyrinsIBA 10/2020
1	Diazepam (Valium)FDA LinkGeneric 08/2020
1	Pilocarpine (Ocusert)FDA LinkGeneric 08/2020
1	Pentylenetetrazole (Metrazol)IBA 08/2020
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 03/2020
1	SynucleinsIBA 03/2020
1	Amyloid beta-PeptidesIBA 02/2019
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 02/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019
1	SA 4503IBA 09/2018
1	ChromatinIBA 01/2016
1	Adenosine (Adenocard)FDA LinkGeneric 10/2015
1	methyl pyruvateIBA 12/2014
1	Methylphenidate (Ritalin)FDA LinkGeneric 04/2014
1	serum P-component (CIt)IBA 07/2013

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2006
4	Oral Administration 10/2020 - 07/2008
2	Ovariectomy (Oophorectomy) 01/2009 - 12/2007
2	Microspheres (Microsphere) 01/2008 - 09/2006